Nektar Therapeutics (NKTR) Stock Price & Financial Analysis
Nektar Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Nektar Therapeutics
What is the current stock price for NKTR?
As of the latest trading session, NKTR stock trades at $69.49. The 52-week range is $7.99–$109.00, with a day range of $67.91–$69.83.
What is the P/E ratio for NKTR?
The P/E ratio (Price-to-Earnings) for NKTR is shown in the Key Statistics section. This valuation metric helps compare Nektar Therapeutics to industry peers.
Does NKTR pay dividends?
Nektar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NKTR?
Based on 6 analysts, the consensus for NKTR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NKTR?
Nektar Therapeutics's market capitalization is $1.41B, classifying it as a small-cap company. Nektar Therapeutics operates in the Healthcare sector within the Biotechnology industry.